Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biovaxys Technology Corp (BVAXD)

Biovaxys Technology Corp (BVAXD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
BioVaxys Strengthens Board with Former Sanofi Executive Tipranks - Thu Oct 9, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

BVAXD : 0.1900 (-13.64%)
BioVaxys Technology Corp. Launches Private Placement to Boost Immunotherapy Pipeline Tipranks - Wed Oct 8, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioVaxys...

BVAXD : 0.1900 (-13.64%)
Stocks in play: BioVaxys Technology Corp. Baystreet - Wed Oct 8, 2025

Announces that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi ...

BVAXD : 0.1900 (-13.64%)
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA") PR Newswire - Mon Sep 29, 2025

The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets

BIOV : N/A (N/A)
BVAXF : 0.1190 (+3.93%)
BVAXD : 0.1900 (-13.64%)
BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING PR Newswire - Tue Sep 16, 2025

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

BIOV : N/A (N/A)
BVAXD : 0.1900 (-13.64%)

Barchart Exclusives

Is Instacart Stock a Buy, Hold or Sell Now? Barchart - 5 minutes ago
With ads and AI scaling, Instacart’s stock may be undervalued. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot